Log in or register
Share on LinkedInShare on LinkedIn

ARTICLE · 10 APRIL 2026

Despite Reduced Enforcement, Strong Compliance Programs Remain Essential

Forensic Risk Alliance
Forensic Risk Alliance
Contributor
Forensic Risk Alliance

Forensic Risk Alliance

Forensic Risk Alliance (FRA) is a global market leader working with our clients to identify,...

View firm profile
Explore more from Forensic Risk Alliance

Despite the decline in corporate enforcement by US authorities since the Trump Administration assumed office, compliance programs remain central to how agencies assess whether to bring an action...

United StatesCorporate/Commercial Law
Neil Keenan
Neil Keenan
Uuljan Djangazieva
Uuljan Djangazieva
Author LinkedIn connections

Despite the decline in corporate enforcement by US authorities since the Trump Administration assumed office, compliance programs remain central to how agencies assess whether to bring an action and determine penalties and post settlement obligations.

US enforcement agencies, such as the Department of Justice (DoJ), Securities and Exchange Commission (SEC), and others continue to view compliance as a proactive, long-term requirement to reform corporate culture, ensure future adherence to laws and regulations, and remediate misconduct. Set out below are recent examples of how corporate compliance programs have recently been considered by key agencies:

US Department of Justice (DoJ)

On March 10, 2026, the DoJ issued its first-ever department-wide Corporate Enforcement and Voluntary Self-Disclosure Policy (CEP), with Deputy Attorney General Todd Blanche emphasising that the policy rewards companies, including a possible "declination" (non-prosecution), for voluntary self-disclosure,

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

Register for freeORLog in

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

View source

Related Articles

Legal Intelligence Newsletters: sign up for the latest legal and regulatory news on your chosen topics

Read more about

Related Comparative Guides

See more popular content from

Article

Healthcare Trends & Transactions Q2 2026

Healthcare M&A activity maintained steady momentum through Q2 2026, driven by physician practice consolidation, AI-enabled technology acquisitions, and strategic outpatient expansion. Private equity investment persisted despite intensifying regulatory scrutiny of MSO arrangements, while digital health buyers paid significant premiums for platforms demonstrating production-grade AI capabilities and proprietary data assets.
United StatesCorporate/Commercial Law
Bass, Berry & Sims PLC
Bass, Berry & Sims PLC
Article

CLIENT ALERT: 2026 Mid-Year Update On SEC And CFTC Enforcement

The SEC and CFTC have fundamentally shifted their enforcement approach in 2026, moving away from high-volume technical violations toward targeted actions addressing serious fraud and market manipulation. This mid-year update examines new leadership priorities, enhanced inter-agency coordination, revised cooperation policies, the elimination of "no-deny" settlement provisions, and a landmark Supreme Court ruling on disgorgement that collectively reshape the regulatory landscape for market participants.
United StatesCorporate/Commercial Law
Sher Tremonte
Sher Tremonte
Article

Sanofi And Regeneron Expand Immunology Collaboration In Deal Worth Up To $8 Billion

Sanofi and Regeneron Pharmaceuticals announce a major expansion of their immunology partnership, committing up to $8 billion to develop and commercialize four long-acting antibodies targeting key inflammatory pathways. The collaboration includes a $1 billion upfront payment and milestone-based payments, with both companies sharing development costs and future profits equally.
United StatesCorporate/Commercial Law
Goodwin Procter LLP
Goodwin Procter LLP
Article

The Forensic Anatomy Of Private Credit Disputes

Private credit has exploded over the past decade, providing borrowers with an increasingly important source of capital and investors with access to attractive yields. But as the market has expanded, so too has the potential for significant disputes when borrowers encounter financial distress, collateral proves insufficient or unreliable, or lenders discover that the information on which they relied does not reflect the underlying reality. This article examines the forensic anatomy of private credit disputes
United StatesFinance and Banking
Forensic Risk Alliance
Forensic Risk Alliance